LONDON & SAN FRANCISCO–(BUSINESS WIRE)–Today, Latent Labs announces Latent-X2, a frontier AI model that can design drug-like biologics without iteration. Drug huntersLONDON & SAN FRANCISCO–(BUSINESS WIRE)–Today, Latent Labs announces Latent-X2, a frontier AI model that can design drug-like biologics without iteration. Drug hunters

Latent Labs Announces Latent-X2: AI-Generated Antibodies With Drug-Like Developability and Low Ex Vivo Immunogenicity

LONDON & SAN FRANCISCO–(BUSINESS WIRE)–Today, Latent Labs announces Latent-X2, a frontier AI model that can design drug-like biologics without iteration. Drug hunters can use Latent Lab’s AI platform, built on Latent-X2, to access difficult targets and accelerate development timelines by reducing wet lab work. The generated designs display drug-like properties including low ex vivo immunogenicity, significantly shortening the path from hit to clinical candidate. Alongside the release, Latent Labs welcomes Stefan Oschmann, former CEO of Merck KGaA, to its strategic advisory board. Latent Labs is opening access to the model for selected partners.

The Development Bottleneck. Current wet lab approaches are costly not merely in development effort but in clinical failure. Hits rarely possess properties needed for clinical success, and optimization to address liabilities frequently fails or produces zero-sum tradeoffs. Suboptimal starting points risk costly downstream failure in clinical programs, and addressing shortcomings requires long development timelines.

Latent Labs Platform. Through the Latent Labs Platform, partners and customers can generate antibodies and peptides for disease targets of their choice. It produces high-affinity binders across VHH, scFv, and macrocyclic peptide formats – approaching drug-like quality from the first generation. The platform provides a scientist-friendly workflow, accessible to customers via web browser or by integrating their own systems with the Latent Labs API.

Zero-Shot Antibody and Peptide Design. Latent-X2 generates antibodies that bind challenging targets from the first generation – achieving hits against half of 18 targets selected for diversity and difficulty, with picomolar to nanomolar affinities and each requiring only 4 to 24 designs. The model generalizes beyond antibodies: macrocyclic peptides bind K-Ras, long considered undruggable, matching or exceeding hits from trillion-scale mRNA display screens while testing 11 orders of magnitude fewer sequences.

Drug-Like by Default. Antibodies designed by Latent-X2 exhibit developability profiles matching or exceeding approved therapeutic controls in head-to-head comparison. This extends to proxies for immunogenicity: in the first such assessment of any AI-generated antibody, de novo VHH binders were evaluated across a ten-donor human panel in ex vivo T-cell activation and cytokine release assays, confirming both potent target engagement and low immunogenicity. While animal studies and clinical trials remain ahead, these results demonstrate that AI-generated molecules can now clear preclinical hurdles that previously required lengthy optimization.

“Semiconductors, satellites and aircraft once required repeated build-test cycles, consuming years and billions of dollars. Today they’re designed computationally before anything is fabricated. With Latent-X2, drug discovery can move towards that same step change – designing the right molecule from the start,” said Simon Kohl, CEO and founder of Latent Labs.

Strategic Advisory Board. Latent Labs announces the appointment of Stefan Oschmann, former CEO of Merck KGaA (until 2021), to its strategic advisory board. “The pharmaceutical industry has spent decades optimizing around the limitations of iterative lab work. Latent Labs is doing something different – building the capability to design molecules that work from first principles. That shift, if it holds, changes the entire logic of drug discovery,” said Oschmann.

Access. Latent-X2 will be available to selected partners. Interest for access can be expressed at partnerships@latentlabs.com.

Latent-X2 builds on the success of Latent-X1, released just five months ago. Latent-X1 has been adopted by industry and academic groups worldwide, who value its performance and no-code interface for real lab applications.

Ten months ago Latent Labs announced its $50M funding round, co-led by Radical Ventures and Sofinnova Partners, with participation by Anthropic’s CEO Dario Amodei, Eleven Labs’ CEO Mati Staniszewski, and Google’s Chief Scientist Jeff Dean. The team includes former AlphaFold 2 co-developers and ex-DeepMind team leads, with experience from Microsoft, Apple, Exscientia, Mammoth Bio, Altos Labs, and Zymergen.

Q&A

Commercial questions

What are the terms for commercial use?

  • Latent-X2 is available on request and through commercial partnerships. For partnership inquiries, reach out to partnerships@latentlabs.com.

How can I get in touch for commercial partnerships?

  • Contact partnerships@latentlabs.com.

Scientific questions

What is a typical application for Latent-X2?

  • Typical applications include the design of antibodies (VHH, scFv) and macrocyclic peptides for drug development programs. The model is particularly suited for generating drug-like antibody molecules.

How is Latent-X2 different from Latent-X1?

  • Latent-X1 focused on macrocyclic peptides and protein mini-binders with strong binding affinities. Latent-X2 advances to antibodies (VHH, scFv) with drug-like developability and demonstrated low ex vivo immunogenicity in initial studies. These profiles emerge without post-generation iteration.

How many designs are typically needed?

  • Latent-X2 achieves strong lab results with 4 to 24 designs per target for antibodies, representing efficiency gains of many orders of magnitude compared to conventional screening methods.

What targets has Latent-X2 been validated against?

  • We tested antibody designs against 18 soluble proteins, achieving picomolar to nanomolar hits against half the targets. Macrocyclic peptides were validated against 2 targets including K-Ras.

Do generated molecules require optimization?

  • In our validation studies, developability profiles emerged directly from the model without iteration, on par or better than approved therapeutics. Nonetheless, we expect some designs to require further development and optimization.

Broader questions

How does Latent Labs ensure safe usage of the technology?

  • Latent Labs actively participates in biosafety and biosecurity discussions with government and regulatory authorities regarding responsible development and preventing potential misuse of emerging technologies. Latent Labs continuously assesses its technologies and restricts access to its services in compliance with international sanctions lists from the EU and UK.

Contacts

contact@latentlabs.com

Market Opportunity
Sleepless AI Logo
Sleepless AI Price(AI)
$0.03831
$0.03831$0.03831
+0.07%
USD
Sleepless AI (AI) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

South Korea Launches Innovative Stablecoin Initiative

South Korea Launches Innovative Stablecoin Initiative

The post South Korea Launches Innovative Stablecoin Initiative appeared on BitcoinEthereumNews.com. South Korea has witnessed a pivotal development in its cryptocurrency landscape with BDACS introducing the nation’s first won-backed stablecoin, KRW1, built on the Avalanche network. This stablecoin is anchored by won assets stored at Woori Bank in a 1:1 ratio, ensuring high security. Continue Reading:South Korea Launches Innovative Stablecoin Initiative Source: https://en.bitcoinhaber.net/south-korea-launches-innovative-stablecoin-initiative
Share
BitcoinEthereumNews2025/09/18 17:54
Trump Cancels Tech, AI Trade Negotiations With The UK

Trump Cancels Tech, AI Trade Negotiations With The UK

The US pauses a $41B UK tech and AI deal as trade talks stall, with disputes over food standards, market access, and rules abroad.   The US has frozen a major tech
Share
LiveBitcoinNews2025/12/17 01:00
Summarize Any Stock’s Earnings Call in Seconds Using FMP API

Summarize Any Stock’s Earnings Call in Seconds Using FMP API

Turn lengthy earnings call transcripts into one-page insights using the Financial Modeling Prep APIPhoto by Bich Tran Earnings calls are packed with insights. They tell you how a company performed, what management expects in the future, and what analysts are worried about. The challenge is that these transcripts often stretch across dozens of pages, making it tough to separate the key takeaways from the noise. With the right tools, you don’t need to spend hours reading every line. By combining the Financial Modeling Prep (FMP) API with Groq’s lightning-fast LLMs, you can transform any earnings call into a concise summary in seconds. The FMP API provides reliable access to complete transcripts, while Groq handles the heavy lifting of distilling them into clear, actionable highlights. In this article, we’ll build a Python workflow that brings these two together. You’ll see how to fetch transcripts for any stock, prepare the text, and instantly generate a one-page summary. Whether you’re tracking Apple, NVIDIA, or your favorite growth stock, the process works the same — fast, accurate, and ready whenever you are. Fetching Earnings Transcripts with FMP API The first step is to pull the raw transcript data. FMP makes this simple with dedicated endpoints for earnings calls. If you want the latest transcripts across the market, you can use the stable endpoint /stable/earning-call-transcript-latest. For a specific stock, the v3 endpoint lets you request transcripts by symbol, quarter, and year using the pattern: https://financialmodelingprep.com/api/v3/earning_call_transcript/{symbol}?quarter={q}&year={y}&apikey=YOUR_API_KEY here’s how you can fetch NVIDIA’s transcript for a given quarter: import requestsAPI_KEY = "your_api_key"symbol = "NVDA"quarter = 2year = 2024url = f"https://financialmodelingprep.com/api/v3/earning_call_transcript/{symbol}?quarter={quarter}&year={year}&apikey={API_KEY}"response = requests.get(url)data = response.json()# Inspect the keysprint(data.keys())# Access transcript contentif "content" in data[0]: transcript_text = data[0]["content"] print(transcript_text[:500]) # preview first 500 characters The response typically includes details like the company symbol, quarter, year, and the full transcript text. If you aren’t sure which quarter to query, the “latest transcripts” endpoint is the quickest way to always stay up to date. Cleaning and Preparing Transcript Data Raw transcripts from the API often include long paragraphs, speaker tags, and formatting artifacts. Before sending them to an LLM, it helps to organize the text into a cleaner structure. Most transcripts follow a pattern: prepared remarks from executives first, followed by a Q&A session with analysts. Separating these sections gives better control when prompting the model. In Python, you can parse the transcript and strip out unnecessary characters. A simple way is to split by markers such as “Operator” or “Question-and-Answer.” Once separated, you can create two blocks — Prepared Remarks and Q&A — that will later be summarized independently. This ensures the model handles each section within context and avoids missing important details. Here’s a small example of how you might start preparing the data: import re# Example: using the transcript_text we fetched earliertext = transcript_text# Remove extra spaces and line breaksclean_text = re.sub(r'\s+', ' ', text).strip()# Split sections (this is a heuristic; real-world transcripts vary slightly)if "Question-and-Answer" in clean_text: prepared, qna = clean_text.split("Question-and-Answer", 1)else: prepared, qna = clean_text, ""print("Prepared Remarks Preview:\n", prepared[:500])print("\nQ&A Preview:\n", qna[:500]) With the transcript cleaned and divided, you’re ready to feed it into Groq’s LLM. Chunking may be necessary if the text is very long. A good approach is to break it into segments of a few thousand tokens, summarize each part, and then merge the summaries in a final pass. Summarizing with Groq LLM Now that the transcript is clean and split into Prepared Remarks and Q&A, we’ll use Groq to generate a crisp one-pager. The idea is simple: summarize each section separately (for focus and accuracy), then synthesize a final brief. Prompt design (concise and factual) Use a short, repeatable template that pushes for neutral, investor-ready language: You are an equity research analyst. Summarize the following earnings call sectionfor {symbol} ({quarter} {year}). Be factual and concise.Return:1) TL;DR (3–5 bullets)2) Results vs. guidance (what improved/worsened)3) Forward outlook (specific statements)4) Risks / watch-outs5) Q&A takeaways (if present)Text:<<<{section_text}>>> Python: calling Groq and getting a clean summary Groq provides an OpenAI-compatible API. Set your GROQ_API_KEY and pick a fast, high-quality model (e.g., a Llama-3.1 70B variant). We’ll write a helper to summarize any text block, then run it for both sections and merge. import osimport textwrapimport requestsGROQ_API_KEY = os.environ.get("GROQ_API_KEY") or "your_groq_api_key"GROQ_BASE_URL = "https://api.groq.com/openai/v1" # OpenAI-compatibleMODEL = "llama-3.1-70b" # choose your preferred Groq modeldef call_groq(prompt, temperature=0.2, max_tokens=1200): url = f"{GROQ_BASE_URL}/chat/completions" headers = { "Authorization": f"Bearer {GROQ_API_KEY}", "Content-Type": "application/json", } payload = { "model": MODEL, "messages": [ {"role": "system", "content": "You are a precise, neutral equity research analyst."}, {"role": "user", "content": prompt}, ], "temperature": temperature, "max_tokens": max_tokens, } r = requests.post(url, headers=headers, json=payload, timeout=60) r.raise_for_status() return r.json()["choices"][0]["message"]["content"].strip()def build_prompt(section_text, symbol, quarter, year): template = """ You are an equity research analyst. Summarize the following earnings call section for {symbol} ({quarter} {year}). Be factual and concise. Return: 1) TL;DR (3–5 bullets) 2) Results vs. guidance (what improved/worsened) 3) Forward outlook (specific statements) 4) Risks / watch-outs 5) Q&A takeaways (if present) Text: <<< {section_text} >>> """ return textwrap.dedent(template).format( symbol=symbol, quarter=quarter, year=year, section_text=section_text )def summarize_section(section_text, symbol="NVDA", quarter="Q2", year="2024"): if not section_text or section_text.strip() == "": return "(No content found for this section.)" prompt = build_prompt(section_text, symbol, quarter, year) return call_groq(prompt)# Example usage with the cleaned splits from Section 3prepared_summary = summarize_section(prepared, symbol="NVDA", quarter="Q2", year="2024")qna_summary = summarize_section(qna, symbol="NVDA", quarter="Q2", year="2024")final_one_pager = f"""# {symbol} Earnings One-Pager — {quarter} {year}## Prepared Remarks — Key Points{prepared_summary}## Q&A Highlights{qna_summary}""".strip()print(final_one_pager[:1200]) # preview Tips that keep quality high: Keep temperature low (≈0.2) for factual tone. If a section is extremely long, chunk at ~5–8k tokens, summarize each chunk with the same prompt, then ask the model to merge chunk summaries into one section summary before producing the final one-pager. If you also fetched headline numbers (EPS/revenue, guidance) earlier, prepend them to the prompt as brief context to help the model anchor on the right outcomes. Building the End-to-End Pipeline At this point, we have all the building blocks: the FMP API to fetch transcripts, a cleaning step to structure the data, and Groq LLM to generate concise summaries. The final step is to connect everything into a single workflow that can take any ticker and return a one-page earnings call summary. The flow looks like this: Input a stock ticker (for example, NVDA). Use FMP to fetch the latest transcript. Clean and split the text into Prepared Remarks and Q&A. Send each section to Groq for summarization. Merge the outputs into a neatly formatted earnings one-pager. Here’s how it comes together in Python: def summarize_earnings_call(symbol, quarter, year, api_key, groq_key): # Step 1: Fetch transcript from FMP url = f"https://financialmodelingprep.com/api/v3/earning_call_transcript/{symbol}?quarter={quarter}&year={year}&apikey={api_key}" resp = requests.get(url) resp.raise_for_status() data = resp.json() if not data or "content" not in data[0]: return f"No transcript found for {symbol} {quarter} {year}" text = data[0]["content"] # Step 2: Clean and split clean_text = re.sub(r'\s+', ' ', text).strip() if "Question-and-Answer" in clean_text: prepared, qna = clean_text.split("Question-and-Answer", 1) else: prepared, qna = clean_text, "" # Step 3: Summarize with Groq prepared_summary = summarize_section(prepared, symbol, quarter, year) qna_summary = summarize_section(qna, symbol, quarter, year) # Step 4: Merge into final one-pager return f"""# {symbol} Earnings One-Pager — {quarter} {year}## Prepared Remarks{prepared_summary}## Q&A Highlights{qna_summary}""".strip()# Example runprint(summarize_earnings_call("NVDA", 2, 2024, API_KEY, GROQ_API_KEY)) With this setup, generating a summary becomes as simple as calling one function with a ticker and date. You can run it inside a notebook, integrate it into a research workflow, or even schedule it to trigger after each new earnings release. Free Stock Market API and Financial Statements API... Conclusion Earnings calls no longer need to feel overwhelming. With the Financial Modeling Prep API, you can instantly access any company’s transcript, and with Groq LLM, you can turn that raw text into a sharp, actionable summary in seconds. This pipeline saves hours of reading and ensures you never miss the key results, guidance, or risks hidden in lengthy remarks. Whether you track tech giants like NVIDIA or smaller growth stocks, the process is the same — fast, reliable, and powered by the flexibility of FMP’s data. Summarize Any Stock’s Earnings Call in Seconds Using FMP API was originally published in Coinmonks on Medium, where people are continuing the conversation by highlighting and responding to this story
Share
Medium2025/09/18 14:40